Alloderm
Alloderm is a medical device with 12 clinical trials. Currently 2 active trials ongoing. Historical success rate of 75.0%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
2
Mid Stage
4
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
66.7%
6 of 9 finished
33.3%
3 ended early
2
trials recruiting
12
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
The Use of Alloderm Versus Dermacell in Immediate Implant Based Breast Reconstruction
Microderm for Root Coverage Procedures
Keratinized Tissue Augmentation Using Porcine Collagen Matrix (Mucoderm®) Around Dental Implant
BREAST ADM Trial for Alloplastic Breast Reconstruction
Vestibular Socket Therapy Using Acellular Dermal Matrix Versus Connective Tissue Graft
Clinical Trials (12)
The Use of Alloderm Versus Dermacell in Immediate Implant Based Breast Reconstruction
Microderm for Root Coverage Procedures
Keratinized Tissue Augmentation Using Porcine Collagen Matrix (Mucoderm®) Around Dental Implant
BREAST ADM Trial for Alloplastic Breast Reconstruction
Vestibular Socket Therapy Using Acellular Dermal Matrix Versus Connective Tissue Graft
Pilot Study for Healing and Safety Outcomes in Gingival Recession
Comparing AlloDerm and DermACELL in Breast Reconstruction
Comparison of Skin Substitutes Used in Burn Care
Bioprosthetic Mesh to Expand the Lower Pole in Tissue Expander Reconstruction
Comparison of FlexHD and Alloderm Outcomes in Breast Reconstructive Surgery
EVPOME Versus AlloDerm in Subjects Reconstructed With Large Defect Mandibular Resection
A Comparison of Dermal Autograft to AlloDerm in Breast Reconstruction
All 12 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 12